Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
Stock detail
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
RLYB
Rallybio Corporation
NASDAQCM
Biotechnology
United States
$16.93
▲
+0.05 (+0.30%)
POST
—
OPEN
$16.82
HIGH
$16.93
AT HIGH
LOW
$16.76
PREV CLOSE
$16.88
VOLUME
4.2K
0.13x avg
BID / ASK
12.14 / 21.84
spr 9.70
MARKET CAP
$89.9M
DAY RANGE
$16.76
$16.93
P/E (TTM)
2.12
Fwd -3.1
EPS (TTM)
7.99
DIV YIELD
—
52W HIGH
$17.57
-3.7%
52W LOW
$3.67
+361.2%
BETA
-0.86
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$16.93
+0.00
(+0.00%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
RLYB
$16.93
▲
+0.30%
Chart
Valuation
Financials
Peers
News
RLYB · K 線技術分析（即時、可互動）
basic
pro
快速分析（約 90–120 秒）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，約 90–120 秒。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
One-Year Trajectory
RISK-ON
252 BARS · +247.4% YOY
1-year price chart. Started at 4.87, currently 16.92, up 247.4 percent. Range 3.99 to 17.00 over 252 data points.
2025-09-05
$4.87 → $16.92 (+247.4%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
EDITORIAL · NOT INVESTMENT ADVICE.
Data sources: Finnhub (quote / profile / news / peers) + Yahoo (stats) + SEC EDGAR XBRL (financials + DCF). All values cached for 5 minutes via ISR.
VALUATION
Deterministic Valuation (SEC EDGAR + Finnhub)
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$166.89
WACC Used
+7.0%
Terminal g
+3.5%
Verdict: strong-buy
· peers $166.89 (+886.1%)
Peers:
ALT
AS PE31
ATI PE62
BRKR
APD
AMZN PE21
AON PE18
BA PE76
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
Multi-Year Financials (SEC XBRL)
RISK-ON
YOY REV +34.9% · 3 FY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
$858.0K
-$9.0M
-$29.8M
—
$62.3M
2024-12
$636.0K
-$57.8M
-$49.3M
-$49.3M
$68.1M
2023-12
—
-$74.6M
-$60.3M
-$60.3M
$115.6M
PEERS
Sector & Industry Peers
CALM
9 PEERS · FINNHUB
ALT
AS
ATI
BRKR
APD
AMZN
AON
BA
CVS
NEWS
Recent News (past 14 days)
—
2 HEADLINES · LAST 14 DAYS
VERAXA Biotech Expands R&D Hub in Heidelberg as Programs Advance Towards Clinical Development
Exec Edge · 2026-06-24
Prolium Bioscience Sclerosis, Lupus Treatment Studies Advancing
Exec Edge · 2026-06-22